Skip to main content
Industry News
Bristol-Myers Squibb to use AI to speed clinical trials

Bristol-Myers Squibb entered an agreement to use Concerto HealthAI's machine-learning technology to accelerate clinical trials, develop synthetic control arms, use real-world evidence in regulatory submissions and validate clinical applications for artificial intelligence.

Full Story: